|

MASCT-I Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • HRYZ Biotech Co.1

Indications

  • Endometrial Stromal Sarcoma1
  • Malignant Peripheral Nerve Sheath Tumors1
  • Desmoplastic Small Round Cell Tumor1
  • Undifferentiated Pleomorphic Sarcoma1
  • Epithelioid Sarcoma1

Other1 trial

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.